Searched for
MANKIND PHARMA ANALYSIS
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Red alert: 15 stocks most vulnerable to FII selling as DIIs refuse to step inForeign institutional investors have divested approximately $53 billion from Indian equities since September 2024, leading to significant o...
- Is your portfolio FII-proof? 7 stocks Jefferies says can defy the $53 billion foreign selloffForeign investors have divested $53 billion from Indian equities since late 2024, leading to underperformance against emerging markets. Dom...
- Rupee at 95, crude at $120+: Why India's markets are flying blind into a stormMarket expert Sudip Bandyopadhyay warns Indian markets face significant risks. High oil prices and a potential monsoon deficit are major co...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%Usually, official talks are mere formalities – meetings to ink things that have already been agreed upon. The one scheduled between the US ...
- Time to increase the risk quotient? Maybe, but selectively: 5 large-caps from different sectors with upside potential of up to 28%With Israel refusing to play ball and Iran maintaining its vice-like hold on the Strait of Hormuz, the ceasefire declared by US President T...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%The market is again abuzz with the possibility of peace in the Gulf. This has, however, happened in the past. There is, thus, no point in g...
- Mankind Pharma shares jump 2% as Morgan Stanley initiates coverage with Overweight call. Check target, upsideMankind Pharma share price surged 2% after Morgan Stanley initiated coverage with an 'Overweight' rating and a Rs 2,500 target price, citin...
- Pharma industry to outdo India Inc in 2025 pay hike: StudyPharma companies in India are projected to offer an average salary increment of 9.6% in 2025, slightly lower than the previous year but sti...
- Daily Trading Desk: 2 trades for short-term gains; pharma firm for almost 6% rise, a mid-cap power infra stock for 7% upmoveSelect stocks gain momentum even in volatile markets.
- Dr Reddy's Labs, Mankind Pharma riding on strong growth driversIndian pharmaceutical giants, Dr. Reddy's Labs and Mankind Pharma, reported impressive double-digit revenue growth in the September quarter...
- IPO lock-in expires, shares of 38 companies worth $21 billion may enter market by NovemberBetween now and November 30, $21 billion worth of shareholder lock-ins across 38 companies will expire. This includes shares from Ceigall I...
- Bino Pathiparampil expects positive momentum in pharma sector; has 3 top picksBino Pathiparampil of Elara Capital discussed the strong Q1 FY25 performance in the pharma sector. Companies like Lupin and Dr Reddy's rece...
- Hitachi Energy, Varun Beverages among 10 stocks with RSI trending upOn August 3, Thursday, StockEdge reported 18 stocks trending up, and ETMarkets has singled out 10 promising stocks from the list. This arti...
- These 7 stocks, including 3 banks may be moved to “largecap” category by AMFI: NuvamaThe Association of Mutual Funds in India (AMFI) is set to release the results of its stock categorization review, with expected changes to ...
- AMFI categorisation review may see 8 stocks entering large- cap club: NuvamaNuvama Quantitative and Alternative Research has identified at least 8 stocks that could make an entry into the large-cap category during t...
Load More
